Medical Health & Life Science Research News

Pharmaceutical excipients market will be worth 8.1 billion USD by 2021 according to new research report

This report studies the pharmaceutical excipients market over the forecast period of 2016-2021. In this report, the pharmaceutical excipients market is segmented by product, delivery form, functionality, and region.

Browse 194 market data tables with 46 figures spread through 256 pages and in-depth TOC on "Pharmaceutical Excipients Market"

www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html

It also discusses the key market trends, drivers, restraints, challenges, and opportunities in this market and its submarkets.

- Advertising -

- Premium. -

The growth of the market is attributed to the increasing demand for functionality excipients, recent patents expiries driving the demand for pharmaceutical excipients in generic drug manufacturing, advancements in nanotechnology, and the emergence of new excipients for the pharmaceutical industry. However, decline in the R&D investments and increasing regulatory requirements are expected to hinder the market growth.

Download the PDF Brochure For FREE@

www.marketsandmarkets.com/pdfdownload.asp?id=956


In 2015, Europe accounted for the largest share of the global pharmaceutical excipients market, followed by North America and Asia-Pacific. The presence of a large number of pharmaceutical excipients manufacturers in the European and North American regions has led to their large shares in the pharmaceutical excipients market.

However, the Asia-Pacific region is projected to register the highest growth during the forecast period.

In 2015, the organic chemicals segment accounted for the largest share of the pharmaceutical excipients market, followed by inorganic chemicals. The large share of organic chemicals can be attributed to the wide applications in the manufacturing of pharmaceutical drugs.

Get The Sample Copy Of This Report:

www.marketsandmarkets.com/requestsample.asp?id=956

Amongst formulations, oral formulations accounted for the largest share of the pharmaceutical excipients market in 2015, owing to the shrinking pipeline of new chemical entities (NCEs), and focus on the development of orally disintegrating tablets (ODTs) and other novel methods of oral drug delivery. There is also a growing trend towards the formulation of sachets.

Topical formulations are expected to grow at the highest CAGR during the forecast period.

The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF SE (Germany), The Dow Chemical Company (U.S.), Roquette (France), FMC Corporation (U.S.), Evonik Industries AG (Germany), Associated British Foods Plc. (U.K.), Archer Daniels Midland Company (U.S.), Lubrizol Corporation (U.S.), and Croda International Plc. (U.K.).

...